Hem › Multipel skleros › Arizona › Scottsdale
Kliniska studier för Multipel skleros i Scottsdale, AZ
4 studier för Multipel skleros söker deltagare vid platser i och runt Scottsdale (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
RekryterarFas 2
- Perseverance Research Center,LLC, Scottsdale
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
RekryterarFas 4
- Clinical Endpoints, LLC, Scottsdale
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
RekryterarObservationsstudie
- TG Therapeutics Investigational Trial Site, Scottsdale
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
RekryterarFas 3
- Perseverance Research Center- Site Number : 8400138, Scottsdale
Multipel skleros-studier i andra städer
- New York City, NY17 studier
- Chicago, IL15 studier
- Boston, MA14 studier
- Washington, DC13 studier
- Cleveland, OH9 studier
- St. Louis, MO8 studier
- Kansas City, KS8 studier
- Birmingham, AL8 studier
- San Francisco, CA8 studier
- Columbus, OH7 studier
- Aurora, CO7 studier
- Baltimore, MD7 studier
Andra studier i Scottsdale
- Cancer (alla typer)18 studier
- Bröstcancer18 studier
- Metastaserande cancer17 studier
- Prostatacancer17 studier
- Icke-småcellig lungcancer15 studier
- Kolorektal cancer15 studier
- Bukspottkörtelcancer13 studier
- Melanom10 studier
- Ulcerös kolit8 studier
- Lungcancer8 studier
- Alzheimers sjukdom7 studier
- Levercancer (hepatocellulärt karcinom)7 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.